Generated by GPT-5-mini| Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico | |
|---|---|
| Name | Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico |
| Location | Milan, Lombardy, Italy |
| Type | Teaching hospital, research institute |
| Affiliation | University of Milan |
| Founded | 1456 (original) |
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico is a major hospital and research institute located in Milan, Lombardy, Italy, affiliated with the University of Milan and designated as an IRCCS institution, serving as a hub for tertiary care, translational research, and medical education. The institution operates within historical complexes linked to the Sforza family and the Duchy of Milan, and interacts with regional health authorities such as the Lombardy Region and national entities including the Ministry of Health (Italy). Its activities bridge clinical services, partnerships with foundations like the Cariplo Foundation and collaborations with international centers such as Mayo Clinic, Karolinska Institute, and Institut Pasteur.
The hospital traces origins to the 15th century foundation of the original Ca' Granda by Francesco Sforza and patronage networks connected to the House of Sforza and the Duchy of Milan, evolving through periods involving the Habsburg Monarchy in Milan, the Napoleonic Kingdom of Italy (1805–1814), and the Kingdom of Italy (1861–1946), with successive expansions during the industrialization that involved ties to the Expo 2015 urban transformations and the post‑World War II reconstruction overseen by Italian republic institutions. During the 20th century the hospital integrated advances from figures associated with the University of Milan, saw wartime impacts linked to the Italian Campaign (World War II), and later reformed governance in line with national health reforms such as laws enacted by the Italian Parliament and policy shifts under various Ministry of Health (Italy) administrations. Recent decades featured designation as an Istituto di Ricovero e Cura a Carattere Scientifico and collaborations with European frameworks including the European Research Council and Horizon programmes administered by the European Commission.
Governance combines statutory boards, scientific committees, and administrative bodies that liaise with the University of Milan, the Lombardy Region, and national regulators such as the Agenas agency; leadership includes a President and Scientific Director accountable to a Board of Directors patterned after models used by entities like the San Raffaele Hospital governance and corporate governance practices familiar to organizations like Istituto Nazionale dei Tumori. The foundation structure aligns with Italian nonprofit corporate frameworks and interacts with funding sources including regional healthcare purchasing authorities, philanthropic institutions such as the Fondazione Cariplo, and European funding agencies including the European Investment Bank for infrastructure projects. Scientific oversight involves committees akin to those at Institut Pasteur and Karolinska Institutet, while ethics review mirrors procedures found at the World Medical Association and regulatory standards referenced by the European Medicines Agency.
Facilities encompass historical buildings on the Via Francesco Sforza campus and modern clinical towers comparable to contemporary developments at Ospedale Niguarda Ca' Granda and San Raffaele Hospital, housing departments such as Cardiology, Oncology, Neurology, Neurosurgery, Pediatrics, Obstetrics and Gynecology, Orthopedics, Emergency Medicine, and specialized centers for Transplantation and Hematology. Diagnostic and therapeutic platforms include advanced imaging suites with equipment standards like those at Mayo Clinic and laboratories engaged in molecular diagnostics comparable to units at Institut Curie, with integrated biobanks and pathology services interfacing with cancer registries and networks such as the Italian Association of Medical Oncology and the European Society for Medical Oncology. Ancillary services coordinate with ambulance providers modeled on systems used by Croce Rossa Italiana and emergency networks in Lombardy.
As an IRCCS, the foundation conducts basic, translational, and clinical research across oncology, cardiology, neurology, immunology, and regenerative medicine, participating in multicenter trials sponsored by organizations like the European Medicines Agency consortia, the National Institutes of Health, and the European Research Council-funded projects. Research units collaborate with the University of Milan faculties, host principal investigators who publish in journals such as The Lancet, Nature Medicine, and The New England Journal of Medicine, and engage in consortia with universities including University College London and Harvard Medical School. Clinical trial management conforms to Good Clinical Practice standards endorsed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and partners with pharmaceutical companies and biotech firms in line with regulatory pathways managed by the Italian Medicines Agency (AIFA).
The foundation is a primary teaching hospital for the University of Milan medical and surgical curricula, providing clerkships, specialty residencies recognized by the Ministry of Health (Italy), doctoral programmes affiliated with the Italian PhD system, and postgraduate fellowships patterned after training at institutions such as Johns Hopkins Hospital and Massachusetts General Hospital. Educational activities include continuing medical education accredited by national bodies, simulation training centers employing methodologies from the European Resuscitation Council, and international exchange programmes with partners like Karolinska Institutet and the Max Planck Society.
The institution has received recognition for clinical and research excellence from national and international bodies, including designations tied to the IRCCS system, contributions to multicenter trials cited in The Lancet Oncology and Circulation, and awards linked to translational breakthroughs similar to honors given by the European Society of Cardiology and the European Society for Medical Oncology. Its researchers have been principal investigators in projects funded by the European Research Council and recipients of grants from the Fondazione Cariplo and national ministries, contributing to landmark studies referenced alongside work from Mayo Clinic, Johns Hopkins University, and Institut Pasteur.
Category:Hospitals in Milan